Sugi Predict

Sugi Predict / Compounds / Triaziquone

Triaziquone

Triaziquone

SCHEMBL588726

C[Si](C)(C)P.O=C1C=C(N2CC2)C(=O)C(N2CC2)=C1N1CC1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ STAT3 P40763 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ DNMT1 P26358 1/20 0.41
▸ KMT2A Q03164 3/20 0.36
▸ APAF1 O14727 3/20 0.36
▸ TDP2 O95551 3/20 0.36
▸ NSD2 O96028 3/20 0.36
▸ HKDC1 Q2TB90 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ GALK1 P51570 2/20 0.36
▸ BLM P54132 2/20 0.36
▸ ATG4B Q9Y4P1 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ NOD2 Q9HC29 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triaziquone SCHEMBL2208738 0.89 MAPT (0.46) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL8303 0.88 DNMT1 (0.48) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL149876 0.86 MAPT (0.46) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL7783197 0.86 MAPT (0.46) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL8482641 0.86 DNMT1 (0.47) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL7738777 0.86 DNMT1 (0.47) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL6000230 0.86 DNMT1 (0.47) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL5054475 0.86 DNMT1 (0.47) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL8993238 0.86 DNMT1 (0.47) MAPTHTTTP53STAT3SMN1; SMN2
Triaziquone SCHEMBL1538515 0.86 DNMT1 (0.47) MAPTHTTTP53STAT3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228871-A9 COMPOSITE QUANTUM DOT, METHOD FOR PREPARING THE SAME, AND METHOD FOR DETECTING METAL ION USING THE SAME UNIV NAT TSING HUA (TW) 2024-07-11 — — US disclosed
US-20240132775-A1 COMPOSITE QUANTUM DOT, METHOD FOR PREPARING THE SAME, AND METHOD FOR DETECTING METAL ION USING THE SAME UNIV NAT TSING HUA (TW) 2024-04-25 — — US disclosed
CN-111117615-B Quantum dot material, preparation method and application thereof, and light-emitting device 深圳市硅光半导体科技有限公司 2022-04-22 — — CN disclosed
CN-111117615-A Quantum dot material, preparation method and application thereof, and light-emitting device 深圳市硅光半导体科技有限公司 2020-05-08 — — CN disclosed
WO-2014209154-A1 ORGANIC LIGHT-EMITTING ELEMENT WITH THE RADIATING LAYER CONTAINING QUANTUM DOTS WITH MODIFIED SURFACE OPTOGAN - ORGANIC LIGHTNING SOLUTION, LLC (OPTOGAN-OSR, LLC) (RU) 2014-12-31 — — WO disclosed
EP-2297384-B1 METHOD OF PREPARING LUMINESCENT NANOCRYSTALS COMMISSARIAT ENERGIE ATOMIQUE (FR) 2012-02-15 — — EP disclosed
WO-2011089985-A1 COSMETIC COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2011-07-28 — — WO disclosed
EP-2297384-A1 METHOD OF PREPARING LUMINESCENT NANOCRYSTALS, THE RESULTING NANOCRYSTALS AND USES THEREOF Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2011-03-23 — — EP disclosed
WO-2009135797-A1 METHOD OF PREPARING LUMINESCENT NANOCRYSTALS, THE RESULTING NANOCRYSTALS AND USES THEREOF COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2009-11-12 — — WO disclosed
WO-1999008688-A1 PHOSPHAZOLE-CONTAINING NUCLEOSIDE ANALOGS, RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN IN VITRO MEDICINAL TREATMENTS ARONEX PHARMACEUTICALS, INC. (US) 1999-02-25 — — WO disclosed